The most consequential question before joining Joi+Blokes is not simply what a month costs. It is which agreement governs the purchase. Its compounded GLP-1 page advertises cancellation at any time, while its general subscription terms describe a three-month minimum and thirty days’ notice before the next monthly processing date. Another policy allows cancellation at any time for an insurance-supported GLP-1 subscription but makes paid fees nonrefundable—even when someone is not a candidate or does not obtain approval.
Those differences deserve attention before payment, not after a prescription decision. Joi+Blokes documents compounded semaglutide, compounded tirzepatide, compounded liraglutide and a separate Zepbound service, alongside broader hormone and wellness offerings. This review examines the public documentation consulted October 19, 2026, focusing on enrollment obligations, separate charges, refund boundaries and responsibility for care. The documentation provides useful detail, but it does not establish which conflicting provision controls every individual plan.
At a glance
- Business structure
- The terms describe Joi+Blokes as a platform connecting customers with third-party medical providers, not a business directly practicing medicine.Sources: [5]
- Compounded plan prices
- Subcutaneous compounded semaglutide is advertised at $179/month, with the first month $99, billed quarterly; subcutaneous compounded tirzepatide is $249/month, with the first month $149, billed quarterly.Sources: [4]
- Zepbound service versus medication
- The service costs $99/month, collected as $297 for three months. Medication is excluded, and the listed Lilly Direct vial purchases are cash-only and ineligible for insurance coverage.Sources: [2]
- Subscription commitment
- General terms require three consecutive months and describe cancellation thirty days before the next monthly processing date after that commitment, despite more flexible language elsewhere.
Start with the cancellation rule, not the enrollment button
Joi+Blokes’ general terms say subscription customers agree to pay for a minimum of three consecutive months. Payment accounts are then charged automatically as described for the relevant product or service. The cancellation clause permits cancellation thirty days before the next monthly processing date, after the initial commitment has concluded. That is materially different from a straightforward month-to-month arrangement in which a customer can stop the next payment immediately.
The compounded GLP-1 page instead advertises “No membership fees” and says customers can adjust or cancel their plan anytime. The insurance-supported GLP-1 policy also allows cancellation at any time. These statements may concern different arrangements, but the consulted documentation does not map each offer cleanly to its controlling conditions. Nor does it explain how quarterly billing interacts with the general terms’ reference to monthly processing.
Before enrolling, request written confirmation of the applicable minimum term, renewal date, notice deadline and cancellation method. Ask whether stopping future renewals also stops an already scheduled order; do not assume it does. Our guide to cancellation notice and renewal dates explains why those are separate questions. A useful answer should identify your specific plan rather than merely repeat the broad promise that cancellation is easy.
What the advertised prices actually purchase
The compounded semaglutide and tirzepatide offers include medication, dosing support, clinician consultations and health coaching. Both advertise monthly prices but quarterly billing. The first-month reductions therefore should not be read as the complete amount collected at enrollment. The exact initial quarterly charge is not stated in the consulted material, and this review does not infer it. Ask for the checkout total and subsequent collection schedule before authorizing payment.
Compounded liraglutide is advertised at $299 per month, with virtual provider visits, personalized coaching, lab access and continuous support. That description does not establish which laboratory charges are covered. Zepbound has a different structure: $297 for a three-month service, expressed as $99 per month, with medication explicitly excluded. The service price and the prescription purchase belong in separate lines of a written quote, not one assumed all-inclusive monthly figure.
The table preserves the advertised distinctions without estimating annual spending or treating a package duration as proof of medication quantity. These are precisely the differences discussed in our guide to monthly prices and billing commitments. For the compounded offers, also confirm what happens financially if a clinician changes the formulation or the plan ends partway through a paid quarter; the public descriptions do not resolve those situations.
| Offer | Advertised payment | Included services or important boundary |
|---|---|---|
| Compounded subcutaneous semaglutide | $179/month; first month $99; billed quarterly | Medication, dosing support, clinician consultations and health coaching; exact initial quarterly charge not stated. |
| Compounded subcutaneous tirzepatide | $249/month; first month $149; billed quarterly | Medication, dosing support, clinician consultations and health coaching; exact initial quarterly charge not stated. |
| Compounded subcutaneous liraglutide | $299/month | Virtual visits, personalized coaching, lab access and continuous support; scope of lab charges not established. |
| Zepbound service | $99/month; $297 for a three-month service | Virtual visits, coaching, lab access and support; medication excluded. |
| Zepbound vials through Lilly Direct | $349/month for 2.5 mg; $499 for 5 mg; $599 for 7.5 mg; $699 for 10 mg | Separate cash-only purchase; these vials are not eligible for insurance coverage; prices subject to change. |
A declined prescription does not have one clear refund outcome
The compounded GLP-1 page says every prescription product requires a consultation with a licensed provider, conducted synchronously or asynchronously. That provider decides whether prescribing is appropriate. The same passage promises an immediate refund when it is not. This is a meaningful enrollment assurance, but it needs to be matched to the actual purchase. “Immediately refunded” also does not establish when money will appear in a customer’s bank account.
The insurance-supported GLP-1 policy takes a different position: if a customer is not a candidate or does not receive approval, the subscription will be canceled and the company will work toward another solution, but fees already paid cannot be refunded. It calls those sales final. Consequently, a customer should not carry the compounded page’s refund assurance into an insurance-supported subscription without written confirmation that it applies.
Other exclusions are explicit. Prescription products cannot be returned, and those sales are final; diagnostic laboratory purchases and laboratory subscriptions are also nonrefundable. The policy directs customers with a suspected prescription error to contact the company, but that is not a general refund guarantee. Our explanation of refund guarantees and exclusions can help organize the questions: which charge is refundable, under which event, and before which fulfillment stage?
The platform, treating clinician and pharmacy have different jobs
The terms identify Joi and Blokes as the website’s owner and operator, while expressly stating that it does not practice medicine or directly provide healthcare services. Instead, it connects users with third-party medical providers. The website identifies Melissa Loseke, DO, as medical director and Lauren Dulay, NP, as director of clinical operations and lead clinician. These are company-stated roles, not independent verification of credentials or identification of every patient’s treating professional.
Enrollment begins with a health-history form and discussion with a licensed clinician; partner providers review the history and decide whether a prescription is appropriate. Informed consent is required before telehealth services. A provider may conclude that an in-person visit or unavailable service is needed, in which case treatment for that particular issue cannot continue through the platform. Payment therefore should not be understood as a guarantee of prescribing or continued remote treatment.
The consulted documentation does not identify the legal clinical group assigned to each patient or establish independently verified professional licensing. Request the treating entity’s name and the contact route for clinical concerns, separately from billing support. Our guide to platform, clinician and pharmacy responsibilities explains this division. It matters especially when an enrollment problem involves both a service fee and a prescription decision made by someone other than the platform operator.
Zepbound creates a separate purchase and insurance boundary
For Zepbound, Joi+Blokes describes a handoff after provider approval: the customer receives a text from Lilly Direct with instructions to complete the medication purchase. The page lists monthly vial prices of $349 for the 2.5 mg presentation, $499 for 5 mg, $599 for 7.5 mg and $699 for 10 mg. Those are presentation-specific prices, not dosing advice. The page warns that prices can change and restricts these vials to cash payment without insurance coverage.
Elsewhere, Joi+Blokes says it helps with prior authorizations and prescription submissions but does not bill insurers directly. Its general discussion says branded medications including Ozempic, Wegovy, Zepbound and Mounjaro may qualify for coverage. That conditional statement does not override the specific cash-only restriction for the listed Lilly Direct Zepbound vials. Ask which dispensing channel and presentation the proposed prescription uses before relying on an insurance benefit.
The Zepbound page advertises payment and receipt within 72 hours after approval and connection by text. That is a provider delivery claim, not a promised clinical-review turnaround. The documentation does not settle how service fees are handled if a customer declines the separate medication purchase. Joi+Blokes also offers eligible HSA/FSA payments through Flex, subject to verification and any required letter approval; remaining balances can be paid through a secondary method.
Optional labs and broad support promises need narrower definitions
The compounded GLP-1 and Zepbound pages state that laboratory testing is not required. Zepbound offers optional Complete Hormone, Advanced and Comprehensive panels. A shared website module asks how testing should be arranged, but that question does not establish a mandatory blood draw for a particular medicine. Likewise, the phrase “lab access” in program descriptions does not establish that tests, specimen collection or every associated charge are included.
Laboratory purchasing has its own conditions. The site advertises a 65% diagnostic-lab discount for new customers using LABS65, without an expiration date in the consulted banner, and says diagnostic prices differ in New York and New Jersey because of local requirements. Combined with the no-refund laboratory policy, those details make a separate itemized lab quote useful. A promotional percentage alone cannot show what the final laboratory purchase will cost.
For compounded plans, Joi+Blokes advertises unlimited health-coach visits, clinician access and support, nutrition and lifestyle support, unlimited messaging, home delivery and a community. It also explains that coaches are not doctors and cannot prescribe, diagnose or provide specific medical advice. The terms warn that provider communications may not occur in real time. Neither “unlimited” messaging nor continuous support establishes a response deadline, scheduled clinical-review frequency or emergency service.
Pharmacy fulfillment leaves several practical questions open
The terms list Strive Pharmacy, Pharmacy Hub, Tailor Made Compounding Pharmacy, Cadre Labs LLC, Empower Pharmacy, LillyDirect Self Pay Pharmacy Solutions doing business as GiftHealth, and Partell Pharmacy as partners dispensing prescriptions for home delivery. This list does not identify which pharmacy will fill a particular order or establish that every listed partner compounds medication. Customers should obtain the assigned pharmacy’s name and contact information before relying on a general platform support channel.
The terms also permit prescriptions to be sent to a selected outside pharmacy. In that case, the customer must obtain the medication and pay that pharmacy directly. The documentation does not explain how choosing an outside pharmacy changes a medication-inclusive plan’s charge. Another concrete limitation is packaging: partner-pharmacy prescriptions may not use child-resistant containers. General preparation and delivery timelines for compounded products and liraglutide, cold-chain procedures, and replacement terms for loss or damage remain undocumented in the consulted material.
FDA guidance supplies an important delivery boundary that the commercial terms should not obscure: do not use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contact the provider or dispensing pharmacy. That is different from assuming a shipment is acceptable because it arrived within an advertised window. Ask in advance who evaluates temperature complaints and who authorizes replacement; a return prohibition does not itself answer either responsibility question.
Availability and product status are not enrollment guarantees
Joi+Blokes says it treats patients and ships medications only within the United States. That does not establish service in every state: the compounded semaglutide page specifically warns that it is unavailable in some states. The terms restrict services to people who have reached the age of majority where they live. The consulted documentation does not provide a complete medication-by-state directory or detailed provider eligibility criteria, so location and suitability need confirmation before payment.
The compounded semaglutide page says concentration and additional ingredients, such as B12, glycine or L-carnitine, depend on individual clinical needs. That makes the actual prescription and formulation relevant contractual details, not interchangeable product labels. Joi+Blokes acknowledges that compounded GLP-1 preparations are not FDA approved. FDA approval concerns a specific product; it does not certify the platform, a partner pharmacy or a compounded preparation because another product contains a similarly named ingredient.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Compounded preparations do not undergo FDA premarket review for safety, effectiveness and quality; nonapproval alone does not prove clinical inequivalence. These distinctions support asking what product is proposed and why. Clear billing terms can improve purchase transparency, but they cannot establish clinical outcomes for Joi+Blokes or its compounded formulations.
Questions & answers
Can I cancel a Joi+Blokes compounded plan whenever I want?
The compounded page says yes, but the general subscription terms describe a three-month minimum and thirty days’ notice before the next monthly processing date after that commitment. The documentation does not reconcile those provisions. Obtain the rule for your exact plan in writing, including when cancellation becomes effective and whether another charge will occur.
Will Joi+Blokes refund me if I cannot get a prescription?
One consultation passage promises an immediate refund when prescribing is inappropriate. The insurance-supported GLP-1 policy instead says paid subscription fees are nonrefundable, even without candidacy or approval. Ask which policy applies before paying and which charges it covers. A refund being issued immediately would not guarantee immediate receipt by your bank.
Does the $99 monthly Zepbound program price include Zepbound?
No. It is a service price, collected as $297 for three months, covering virtual visits, coaching, lab access and support. Medication is separate. The page lists presentation-specific Lilly Direct vial prices from $349 to $699 per month, subject to change, and says those vials require cash payment and are not eligible for insurance coverage.
Are blood tests mandatory or included?
The compounded GLP-1 and Zepbound pages say labs are not required. Zepbound offers three optional panels. References to lab access and a testing-arrangement module do not establish that a particular test is mandatory or paid for by the program. Request an itemized price before purchasing; diagnostic labs and lab subscriptions are described as nonrefundable.
Can I have a prescription sent to my own pharmacy?
The terms allow a prescription to be sent to a selected pharmacy outside the partner network. You would then be responsible for obtaining the medication and paying that pharmacy directly. Ask how this affects any medication-inclusive program charge, because the consulted documentation does not explain an offset, credit or revised service-only price.
Does unlimited messaging mean an immediate clinician response?
No response-time guarantee is documented. The compounded page advertises unlimited messaging and clinician support, while the terms warn that communications may not occur in real time. Health coaches cannot prescribe, diagnose or provide specific medical advice. Ask for separate clinical and administrative contact routes, expected response times and the process for arranging a clinician review.
Our assessment
Joi+Blokes provides useful purchase-level detail: named medication options, quarterly billing for two compounded plans, a clearly separate Zepbound service fee, pharmacy partners and defined coaching limits. Its principal documentary weakness is the unresolved relationship between flexible cancellation language, a minimum subscription term and conflicting refund provisions. Those differences can materially change the cost of an unsuccessful enrollment or an early exit. Before authorizing payment, obtain a plan-specific written statement of the initial charge, renewal schedule, commitment, notice deadline, refund conditions and responsible clinical and pharmacy entities. The public documentation supports a serious comparison, but not an assumption that every advertised flexibility applies to every program.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.